A Phase II Trial of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Hormone Resistant Prostate Cancer (HRPC)
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Celecoxib; Epirubicin; Estramustine
- Indications Prostate cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 05 Mar 2010 Interim results (n=14) presented at ASCO Genitourinary Cancers Symposium 2010.
- 03 Nov 2005 New trial record.